THANK YOU FOR SUBSCRIBING
A Dublin-based tech start-up has announced the launch of Wirano, which is a digital platform for rapid and effective clinical trials.
FREMONT, CA: Dublin-based tech start-up has announced the launch of Wirano. It is a digital platform for rapid and effective organization of clinical trials. Furthermore, the forum's motive is to revolutionize the activities used in clinical trials by increasing the speed of the start-up of trials, optimizing patient recruitment, and enhancing the site and investigator selection procedure.
"The enormous cost of clinical trials in terms of time, money and effort is well known. The average clinical trial process lasts between 7.5 and 12 years with costs ranging from $161M - $2.6B per drug. Yet in spite of this investment, the success rate of clinical trials is just 14% (1)," said Noel Quinn, Commercial Director. "Wirano aims to improve this rate of success by optimizing the patient recruitment process, improving site selection procedures and creating reliable channels for effective communications between all participants."
One of the primary difficulties is searching and choosing patients for trials due to which almost 50 percent of every planned trial does not accomplish recruitment targets on time. It becomes difficult for the organizers of clinical trials to select a research center with reliable data on previous experience and patient enrollment in most situations. The deficiency of a single database of centers from various countries and the absence of reliable and efficient communication channels with research teams further intensifies the situation. Wirano is designed to allow every participant of clinical trials, including pharmaceutical companies, medical researchers, and patients, to communicate during the procedure efficiently.
Wirano will utilize pharmaceutical organizations (sponsors) to choose the research teams in various countries quickly. The doctors can even promptly post information about the clinical trials for patients and start recruiting. The patients will have the chance to find a suitable clinical trial in a matter of minutes and apply for participation in it.